Director, Global Program Lead, External Innovation & Due Diligence

Role: Lead external opportunity due diligence for clinical-stage assets within neuroscience, psychiatry, and rare diseases, supporting strategic evaluations and potential transactions. Responsibilities: coordinate cross-functional assessments involving Clinical, Nonclinical, Regulatory, CMC, Commercial, Finance, and Legal teams; develop diligence workplans, risk assessments, and integrated development scenarios; evaluate scientific rationale, clinical and regulatory considerations, and commercial potential; synthesize complex data into clear recommendations for senior leadership and support external partnerships and in-licensing activities. Requirements: bachelor’s degree in a relevant science; 10-12 years in pharma/biotech, with experience in R&D program management of clinical-stage assets; expertise in neuroscience or rare diseases preferred; strong scientific, strategic, and cross-functional collaboration skills; understanding of drug development and industry dynamics; ability to operate in a fast-paced environment and manage multiple priorities. HighValue: clinical-stage assets, neuroscience/rare diseases, portfolio strategy, external asset evaluation, cross-functional leadership, global R&D experience, strategic and investment decision support. WorkSetup: hybrid model with in-office presence in San Diego, San Francisco, or Princeton; domestic and international travel.